-
1
-
-
70450199115
-
-
Erratum in: J Am Coll Cardiol 2010;55:612. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
Kushner FG, Hand M, Smith SC Jr, King SB III, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;54:2205-41. Erratum in: J Am Coll Cardiol 2010;55:612.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 2205-2241
-
-
Kushner, F.G.1
Hand, M.2
Smith Jr, S.C.3
King III, S.B.4
Anderson, J.L.5
Antman, E.M.6
Bailey, S.R.7
Bates, E.R.8
Blankenship, J.C.9
Casey Jr, D.E.10
Green, L.A.11
Hochman, J.S.12
Jacobs, A.K.13
Krumholz, H.M.14
Morrison, D.A.15
Ornato, J.P.16
Pearle, D.L.17
Peterson, E.D.18
Sloan, M.A.19
Whitlow, P.L.20
more..
-
2
-
-
77958128969
-
European Association for Percutaneous Cardiovascular Interventions, Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
-
Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, et al. European Association for Percutaneous Cardiovascular Interventions, Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 2501-55.
-
(2010)
Eur Heart J
, vol.31
, pp. 2501-2555
-
-
Wijns, W.1
Kolh, P.2
Danchin, N.3
Di Mario, C.4
Falk, V.5
Folliguet, T.6
Garg, S.7
Huber, K.8
James, S.9
Knuuti, J.10
Lopez-Sendon, J.11
Marco, J.12
Menicanti, L.13
Ostojic, M.14
Piepoli, M.F.15
Pirlet, C.16
Pomar, J.L.17
Reifart, N.18
Ribichini, F.L.19
Schalij, M.J.20
more..
-
3
-
-
36148985732
-
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials
-
De Luca G, Marino P. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials. Am Heart J 2007; 154: 1085.e1-6.
-
(2007)
Am Heart J
, vol.154
-
-
De Luca, G.1
Marino, P.2
-
4
-
-
80053415124
-
-
The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Accessed 24 January
-
The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Accessed 24 January2011.
-
(2011)
-
-
-
5
-
-
0034685429
-
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group
-
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
-
(2000)
JAMA
, vol.283
, pp. 2008-2012
-
-
Stroup, D.F.1
Berlin, J.A.2
Morton, S.C.3
Olkin, I.4
Williamson, G.D.5
Rennie, D.6
Moher, D.7
Becker, B.J.8
Sipe, T.A.9
Thacker, S.B.10
-
6
-
-
79951477846
-
Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology
-
Navarese EP, Kozinski M, Pafundi T, Andreotti F, Buffon A, Servi SD, Kubica J. Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology. Cardiol J 2011; 18: 3-7.
-
(2011)
Cardiol J
, vol.18
, pp. 3-7
-
-
Navarese, E.P.1
Kozinski, M.2
Pafundi, T.3
Andreotti, F.4
Buffon, A.5
Servi, S.D.6
Kubica, J.7
-
7
-
-
0023025908
-
Analysis of data from multiclinics trials
-
Fleiss JL. Analysis of data from multiclinics trials. Control Clin Trials 1986; 7: 267-75.
-
(1986)
Control Clin Trials
, vol.7
, pp. 267-275
-
-
Fleiss, J.L.1
-
9
-
-
0032477417
-
Bias in location and selection of studies
-
Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998; 31: 61-6.
-
(1998)
BMJ
, vol.31
, pp. 61-66
-
-
Egger, M.1
Smith, G.D.2
-
10
-
-
0033934949
-
Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
-
Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-63.
-
(2000)
Biometrics
, vol.56
, pp. 455-463
-
-
Duval, S.1
Tweedie, R.2
-
11
-
-
0029785769
-
The relation between treatment benefit and underlying risk in meta-analysis
-
Sharp SJ, Thompson SG, Altman DG. The relation between treatment benefit and underlying risk in meta-analysis. BMJ 1996; 313: 735-8.
-
(1996)
BMJ
, vol.313
, pp. 735-738
-
-
Sharp, S.J.1
Thompson, S.G.2
Altman, D.G.3
-
12
-
-
10744220109
-
Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab
-
Dubois CL, Belmans A, Granger CB, Armstrong PW, Wallentin L, Fioretti PM, López-Sendón JL, Verheugt FW, Meyer J, van de Werf F. Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab. J Am Coll Cardiol 2003; 42: 1178-85.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 1178-1185
-
-
Dubois, C.L.1
Belmans, A.2
Granger, C.B.3
Armstrong, P.W.4
Wallentin, L.5
Fioretti, P.M.6
López-Sendón, J.L.7
Verheugt, F.W.8
Meyer, J.9
van de Werf, F.10
-
13
-
-
79751519297
-
Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention
-
Brieger D, Collet JP, Silvain J, Landivier A, Barthélémy O, Beygui F, Bellemain-Appaix A, Mercadier A, Choussat R, Vignolles N, Costagliola D, Montalescot G. Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention. Catheter Cardiovasc Interv 2011; 77: 182-90.
-
(2011)
Catheter Cardiovasc Interv
, vol.77
, pp. 182-190
-
-
Brieger, D.1
Collet, J.P.2
Silvain, J.3
Landivier, A.4
Barthélémy, O.5
Beygui, F.6
Bellemain-Appaix, A.7
Mercadier, A.8
Choussat, R.9
Vignolles, N.10
Costagliola, D.11
Montalescot, G.12
-
14
-
-
33644876597
-
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial
-
Sabatine MS, Morrow DA, Montalescot G, Dellborg M, Leiva-Pons JL, Keltai M, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald E. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation 2005; 112: 3846-54.
-
(2005)
Circulation
, vol.112
, pp. 3846-3854
-
-
Sabatine, M.S.1
Morrow, D.A.2
Montalescot, G.3
Dellborg, M.4
Leiva-Pons, J.L.5
Keltai, M.6
Murphy, S.A.7
McCabe, C.H.8
Gibson, C.M.9
Cannon, C.P.10
Antman, E.M.11
Braunwald, E.12
-
15
-
-
34249824588
-
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial
-
Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, Gulba DC, Kracoff OH, Lewis BS, Roguin N, Antman EM, Braunwald E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol 2007; 49: 2238-46.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 2238-2246
-
-
Gibson, C.M.1
Murphy, S.A.2
Montalescot, G.3
Morrow, D.A.4
Ardissino, D.5
Cohen, M.6
Gulba, D.C.7
Kracoff, O.H.8
Lewis, B.S.9
Roguin, N.10
Antman, E.M.11
Braunwald, E.12
-
16
-
-
76649119159
-
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)
-
Montalescot G, Ellis SG, de Belder MA, Janssens L, Katz O, Pluta W, Ecollan P, Tendera M, van Boven AJ, Widimsky P, Andersen HR, Betriu A, Armstrong P, Brodie BR, Herrmann HC, Neumann FJ, Effron MB, Lu J, Barnathan ES, Topol EJ. Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). JACC Cardiovasc Interv 2010; 3: 203-12.
-
(2010)
JACC Cardiovasc Interv
, vol.3
, pp. 203-212
-
-
Montalescot, G.1
Ellis, S.G.2
de Belder, M.A.3
Janssens, L.4
Katz, O.5
Pluta, W.6
Ecollan, P.7
Tendera, M.8
van Boven, A.J.9
Widimsky, P.10
Andersen, H.R.11
Betriu, A.12
Armstrong, P.13
Brodie, B.R.14
Herrmann, H.C.15
Neumann, F.J.16
Effron, M.B.17
Lu, J.18
Barnathan, E.S.19
Topol, E.J.20
more..
-
17
-
-
62549115733
-
Enoxaparin vs. non-fractionated heparin in primary angioplasty of acute myocardial infarction
-
Galeote G, Moreno R, Sánchez-Recalde A, Jiménez-Valero S, Calvo L, Rivero F, Gallegos JF, López de Sa E, Sobrino JA, López-Sendón JL. Enoxaparin vs. non-fractionated heparin in primary angioplasty of acute myocardial infarction. Med Intensiva 2009; 33: 1-7.
-
(2009)
Med Intensiva
, vol.33
, pp. 1-7
-
-
Galeote, G.1
Moreno, R.2
Sánchez-Recalde, A.3
Jiménez-Valero, S.4
Calvo, L.5
Rivero, F.6
Gallegos, J.F.7
López de Sa, E.8
Sobrino, J.A.9
López-Sendón, J.L.10
-
18
-
-
56149103295
-
Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen
-
Khoobiar S, Mejevoi N, Kaid K, Boiangiu C, Setty S, Tanwir A, Khalid K, Cohen M. Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen. J Thromb Thrombolysis 2008; 26: 85-90.
-
(2008)
J Thromb Thrombolysis
, vol.26
, pp. 85-90
-
-
Khoobiar, S.1
Mejevoi, N.2
Kaid, K.3
Boiangiu, C.4
Setty, S.5
Tanwir, A.6
Khalid, K.7
Cohen, M.8
-
19
-
-
77950144610
-
Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents
-
Li YJ, Rha SW, Chen KY, Poddar KL, Jin Z, Minami Y, Wang L, Dang Q, Li GP, Ramasamy S, Park JY, Choi CU, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ, Jeong MH, Ahn YK, Hong TJ, et al. Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents. Am Heart J 2010; 159: 684-90.
-
(2010)
Am Heart J
, vol.159
, pp. 684-690
-
-
Li, Y.J.1
Rha, S.W.2
Chen, K.Y.3
Poddar, K.L.4
Jin, Z.5
Minami, Y.6
Wang, L.7
Dang, Q.8
Li, G.P.9
Ramasamy, S.10
Park, J.Y.11
Choi, C.U.12
Kim, J.W.13
Kim, E.J.14
Park, C.G.15
Seo, H.S.16
Oh, D.J.17
Jeong, M.H.18
Ahn, Y.K.19
Hong, T.J.20
more..
-
20
-
-
63049140130
-
Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention
-
Zeymer U, Gitt A, Zahn R, Jünger C, Bauer T, Heer T, Koeth O, Senges J. Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. EuroIntervention 2009; 4: 524-8.
-
(2009)
EuroIntervention
, vol.4
, pp. 524-528
-
-
Zeymer, U.1
Gitt, A.2
Zahn, R.3
Jünger, C.4
Bauer, T.5
Heer, T.6
Koeth, O.7
Senges, J.8
-
21
-
-
0037446207
-
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study)
-
Montalescot G, Bal-dit-Sollier C, Chibedi D, Collet JP, Soulat T, Dalby M, Choussat R, Cohen A, Slama M, Steg PG, Dubois-Randé JL, Metzger JP, Tarragano F, Guermonprez JL, Drouet L. Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study). Am J Cardiol 2003; 91: 925-30.
-
(2003)
Am J Cardiol
, vol.91
, pp. 925-930
-
-
Montalescot, G.1
Bal-dit-Sollier, C.2
Chibedi, D.3
Collet, J.P.4
Soulat, T.5
Dalby, M.6
Choussat, R.7
Cohen, A.8
Slama, M.9
Steg, P.G.10
Dubois-Randé, J.L.11
Metzger, J.P.12
Tarragano, F.13
Guermonprez, J.L.14
Drouet, L.15
-
22
-
-
14644424575
-
Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: an ENTIRE-TIMI 23 substudy
-
Ray KK, Morrow DA, Gibson CM, Murphy S, Antman EM, Braunwald E. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: an ENTIRE-TIMI 23 substudy. Eur Heart J 2005; 26: 440-6.
-
(2005)
Eur Heart J
, vol.26
, pp. 440-446
-
-
Ray, K.K.1
Morrow, D.A.2
Gibson, C.M.3
Murphy, S.4
Antman, E.M.5
Braunwald, E.6
-
23
-
-
18144439840
-
Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina
-
Montalescot G, Collet JP, Lison L, Choussat R, Ankri A, Vicaut E, Perlemuter K, Philippe F, Drobinski G, Thomas D. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol 2000; 36: 110-4.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 110-114
-
-
Montalescot, G.1
Collet, J.P.2
Lison, L.3
Choussat, R.4
Ankri, A.5
Vicaut, E.6
Perlemuter, K.7
Philippe, F.8
Drobinski, G.9
Thomas, D.10
-
24
-
-
33748431522
-
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention
-
Montalescot G, White HD, Gallo R. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med 2006; 355: 1006-17.
-
(2006)
N Engl J Med
, vol.355
, pp. 1006-1017
-
-
Montalescot, G.1
White, H.D.2
Gallo, R.3
-
25
-
-
52949097563
-
Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study
-
Montalescot G, Öngen Z, Guindy R, Sousa A, Lu SZ, Pahlajani D, Pellois A, Vicaut E. Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study. Int J Cardiol 2008; 129: 379-87.
-
(2008)
Int J Cardiol
, vol.129
, pp. 379-387
-
-
Montalescot, G.1
Öngen, Z.2
Guindy, R.3
Sousa, A.4
Lu, S.Z.5
Pahlajani, D.6
Pellois, A.7
Vicaut, E.8
-
26
-
-
21144439571
-
Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial)
-
Madan M, Radhakrishnan S, Reis M, Paradiso-Hardy FL, Godin-Edgecombe M, Sparling C, Phillips AM, Shanmugasegaram S, Fort S, Naqvi SZ, Cohen EA. Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial). Am J Cardiol 2005; 95: 1295-301.
-
(2005)
Am J Cardiol
, vol.95
, pp. 1295-1301
-
-
Madan, M.1
Radhakrishnan, S.2
Reis, M.3
Paradiso-Hardy, F.L.4
Godin-Edgecombe, M.5
Sparling, C.6
Phillips, A.M.7
Shanmugasegaram, S.8
Fort, S.9
Naqvi, S.Z.10
Cohen, E.A.11
-
27
-
-
0032711331
-
Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris
-
Rabah MM, Premmereur J, Graham M, Fareed J, Hoppensteadt DA, Grines LL, Grines CL. Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris. Am J Cardiol 1999; 84: 1391-5.
-
(1999)
Am J Cardiol
, vol.84
, pp. 1391-1395
-
-
Rabah, M.M.1
Premmereur, J.2
Graham, M.3
Fareed, J.4
Hoppensteadt, D.A.5
Grines, L.L.6
Grines, C.L.7
-
28
-
-
8544279582
-
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events study group
-
Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events study group. N Engl J Med 1997; 337: 447-52.
-
(1997)
N Engl J Med
, vol.337
, pp. 447-452
-
-
Cohen, M.1
Demers, C.2
Gurfinkel, E.P.3
Turpie, A.G.4
Fromell, G.J.5
Goodman, S.6
Langer, A.7
Califf, R.M.8
Fox, K.A.9
Premmereur, J.10
Bigonzi, F.11
-
29
-
-
0032870952
-
Enoxaparin prevents death and cardiac ischemic events inunstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial
-
Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E. Enoxaparin prevents death and cardiac ischemic events inunstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999; 100: 1593-601.
-
(1999)
Circulation
, vol.100
, pp. 1593-1601
-
-
Antman, E.M.1
McCabe, C.H.2
Gurfinkel, E.P.3
Turpie, A.G.4
Bernink, P.J.5
Salein, D.6
Bayes De Luna, A.7
Fox, K.8
Lablanche, J.M.9
Radley, D.10
Premmereur, J.11
Braunwald, E.12
-
30
-
-
0036735080
-
Randomized double blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin
-
Cohen M, Theroux P, Borzak S, Frey MJ, White HD, van Mieghem W, Senatore F, Lis J, Mukherjee R, Harris K, Bigonzi F. Randomized double blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin. Am Heart J 2002; 144: 470-7.
-
(2002)
Am Heart J
, vol.144
, pp. 470-477
-
-
Cohen, M.1
Theroux, P.2
Borzak, S.3
Frey, M.J.4
White, H.D.5
van Mieghem, W.6
Senatore, F.7
Lis, J.8
Mukherjee, R.9
Harris, K.10
Bigonzi, F.11
-
31
-
-
0037458122
-
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated Enoxaparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide
-
Goodman SG, Fitchett D, Armstrong PW, Tan M, Langer A. Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated Enoxaparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Circulation 2003; 107: 238-44.
-
(2003)
Circulation
, vol.107
, pp. 238-244
-
-
Goodman, S.G.1
Fitchett, D.2
Armstrong, P.W.3
Tan, M.4
Langer, A.5
-
32
-
-
3042820414
-
Safety and efficacy of enoxaparin vs. unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial
-
Blazing MA, de Lemos JA, White HD, Fox KA, Verheugt FW, Ardissino D, Dibattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM. Safety and efficacy of enoxaparin vs. unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA 2004; 292: 55-64.
-
(2004)
JAMA
, vol.292
, pp. 55-64
-
-
Blazing, M.A.1
de Lemos, J.A.2
White, H.D.3
Fox, K.A.4
Verheugt, F.W.5
Ardissino, D.6
Dibattiste, P.M.7
Palmisano, J.8
Bilheimer, D.W.9
Snapinn, S.M.10
Ramsey, K.E.11
Gardner, L.H.12
Hasselblad, V.13
Pfeffer, M.A.14
Lewis, E.F.15
Braunwald, E.16
Califf, R.M.17
-
33
-
-
3042782723
-
Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial
-
Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, Kereiakes DJ, Langer A, Mahaffey KW, Nessel CC, Armstrong PW, Avezum A, Aylward P, Becker RC, Biasucci L, Borzak S, Col J, Frey MJ, Fry E, Gulba DC, et al. Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004; 292: 45-54.
-
(2004)
JAMA
, vol.292
, pp. 45-54
-
-
Ferguson, J.J.1
Califf, R.M.2
Antman, E.M.3
Cohen, M.4
Grines, C.L.5
Goodman, S.6
Kereiakes, D.J.7
Langer, A.8
Mahaffey, K.W.9
Nessel, C.C.10
Armstrong, P.W.11
Avezum, A.12
Aylward, P.13
Becker, R.C.14
Biasucci, L.15
Borzak, S.16
Col, J.17
Frey, M.J.18
Fry, E.19
Gulba, D.C.20
more..
-
34
-
-
0036554907
-
Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction
-
Baird SH, Menown IBA, McBride SJ, Trouton TG, Wilson C. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. Eur Heart J 2002; 23: 627-32.
-
(2002)
Eur Heart J
, vol.23
, pp. 627-632
-
-
Baird, S.H.1
Menown, I.B.A.2
McBride, S.J.3
Trouton, T.G.4
Wilson, C.5
-
35
-
-
36148996461
-
Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction
-
Wang XK, Zhang Y, Yang CM, Wang Y, Liu GY. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction. Clin Drug Investig 2006; 26: 341-9.
-
(2006)
Clin Drug Investig
, vol.26
, pp. 341-349
-
-
Wang, X.K.1
Zhang, Y.2
Yang, C.M.3
Wang, Y.4
Liu, G.Y.5
-
36
-
-
0035822605
-
Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractioned heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin. Second trial of Heparin and Aspirin Reperfusion Therapy (HART-II)
-
Ross AM, Molhoek P, Lundergan C, Knudtson M, Draoui Y, Regalado L, Le Louer V, Bigonzi F, Schwartz W, de Jong E, Coyne K. Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractioned heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin. Second trial of Heparin and Aspirin Reperfusion Therapy (HART-II). Circulation 2001; 104: 648-52.
-
(2001)
Circulation
, vol.104
, pp. 648-652
-
-
Ross, A.M.1
Molhoek, P.2
Lundergan, C.3
Knudtson, M.4
Draoui, Y.5
Regalado, L.6
Le Louer, V.7
Bigonzi, F.8
Schwartz, W.9
de Jong, E.10
Coyne, K.11
-
37
-
-
0038447936
-
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction
-
Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AA, Arntz HR, Bogaerts K, Danays T, Lindahl B, Mäkijärvi M, Verheugt F, van de Werf F. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 2003; 108: 135-42.
-
(2003)
Circulation
, vol.108
, pp. 135-142
-
-
Wallentin, L.1
Goldstein, P.2
Armstrong, P.W.3
Granger, C.B.4
Adgey, A.A.5
Arntz, H.R.6
Bogaerts, K.7
Danays, T.8
Lindahl, B.9
Mäkijärvi, M.10
Verheugt, F.11
van de Werf, F.12
-
38
-
-
0038814322
-
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction - the ASSENT Plus study
-
Wallentin L, Bergstrand L, Dellborg M, Fellenius C, Granger CB, Lindahl B, Lins LE, Nilsson T, Pehrsson K, Siegbahn A, Swahn E. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction - the ASSENT Plus study. Eur Heart J 2003; 24: 897-908.
-
(2003)
Eur Heart J
, vol.24
, pp. 897-908
-
-
Wallentin, L.1
Bergstrand, L.2
Dellborg, M.3
Fellenius, C.4
Granger, C.B.5
Lindahl, B.6
Lins, L.E.7
Nilsson, T.8
Pehrsson, K.9
Siegbahn, A.10
Swahn, E.11
-
39
-
-
33645515458
-
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction
-
Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, López-Sendón JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald E. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 2006; 354: 1477-88.
-
(2006)
N Engl J Med
, vol.354
, pp. 1477-1488
-
-
Antman, E.M.1
Morrow, D.A.2
McCabe, C.H.3
Murphy, S.A.4
Ruda, M.5
Sadowski, Z.6
Budaj, A.7
López-Sendón, J.L.8
Guneri, S.9
Jiang, F.10
White, H.D.11
Fox, K.A.12
Braunwald, E.13
-
40
-
-
32544460858
-
Prehospital administration of enoxaparin before primary angioplasty for ST-elevation acute myocardial infarction
-
Labè;que JN, Jaïs C, Dubos O, Denard M, Berhouet M, Leroux L, Laplace G, Vergnes C, Pradeau C, Thicoïpe M, Dos Santos P, Coste P. Prehospital administration of enoxaparin before primary angioplasty for ST-elevation acute myocardial infarction. Catheter Cardiovasc Interv 2006; 67: 207-13.
-
(2006)
Catheter Cardiovasc Interv
, vol.67
, pp. 207-213
-
-
Labè1
que, J.N.2
Jaïs, C.3
Dubos, O.4
Denard, M.5
Berhouet, M.6
Leroux, L.7
Laplace, G.8
Vergnes, C.9
Pradeau, C.10
Thicoïpe, M.11
Dos Santos, P.12
Coste, P.13
-
41
-
-
80053397510
-
Use of low molecular weight heparin is associated with improved in-hospital survival of ST-elevation myocardial infarction patients who receive reperfusion therapy: results from the nationwide French FAST-MI registry
-
Danchin N, Collet J, Marco J, Charbonnier B, Cottin Y, Sans P, Puel J, Dentan G, Cambou JP. Use of low molecular weight heparin is associated with improved in-hospital survival of ST-elevation myocardial infarction patients who receive reperfusion therapy: results from the nationwide French FAST-MI registry. J Am Coll Cardiol 2007; 49: 184A-253A.
-
(2007)
J Am Coll Cardiol
, vol.49
-
-
Danchin, N.1
Collet, J.2
Marco, J.3
Charbonnier, B.4
Cottin, Y.5
Sans, P.6
Puel, J.7
Dentan, G.8
Cambou, J.P.9
-
42
-
-
38349106680
-
Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction
-
Zeymer U, Gitt A, Jünger C, Jünger C, Bauer T, Heer T, Koeth O, Senges J. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction. Thromb Haemost 2008; 99: 150-4.
-
(2008)
Thromb Haemost
, vol.99
, pp. 150-154
-
-
Zeymer, U.1
Gitt, A.2
Jünger, C.3
Jünger, C.4
Bauer, T.5
Heer, T.6
Koeth, O.7
Senges, J.8
-
43
-
-
78449303538
-
Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor
-
Cho JS, Her SH, Baek JY, Park MW, Kim HD, Jeong MH, Ahn Y, Chae SC, Hur SH, Hong TJ, Kim YJ, Seong IW, Chae JK, Rhew JY, Chae IH, Cho MC, Bae JH, Rha SW, Kim CJ, Choi D, et al. Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor. J Korean Med Sci 2010; 25: 1601-8.
-
(2010)
J Korean Med Sci
, vol.25
, pp. 1601-1608
-
-
Cho, J.S.1
Her, S.H.2
Baek, J.Y.3
Park, M.W.4
Kim, H.D.5
Jeong, M.H.6
Ahn, Y.7
Chae, S.C.8
Hur, S.H.9
Hong, T.J.10
Kim, Y.J.11
Seong, I.W.12
Chae, J.K.13
Rhew, J.Y.14
Chae, I.H.15
Cho, M.C.16
Bae, J.H.17
Rha, S.W.18
Kim, C.J.19
Choi, D.20
more..
|